Found: 80
Select item for more details and to access through your institution.
Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.
- Published in:
- Annals of the New York Academy of Sciences, 2016, v. 1363, n. 1, p. 125, doi. 10.1111/nyas.12987
- By:
- Publication type:
- Article
An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy.
- Published in:
- Angewandte Chemie, 2017, v. 129, n. 46, p. 14904, doi. 10.1002/ange.201709532
- By:
- Publication type:
- Article
Single amino acid chelate complexes of the M(CO)<sub>3</sub><sup>+</sup> core for correlating fluorescence and radioimaging studies (M = <sup>99m</sup>Tc or Re).
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 4, p. 255, doi. 10.1002/jlcr.3164
- By:
- Publication type:
- Article
Preliminary evaluation of prostate-targeted radiotherapy using <sup>131</sup>I- MIP-1095 in combination with radiosensitising chemotherapeutic drugs.
- Published in:
- Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 7, p. 912, doi. 10.1111/jphp.12558
- By:
- Publication type:
- Article
An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy.
- Published in:
- Angewandte Chemie International Edition, 2017, v. 56, n. 46, p. 14712, doi. 10.1002/anie.201709532
- By:
- Publication type:
- Article
P2‐395: PERIORBITAL CSF CLEARANCE IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P756, doi. 10.1016/j.jalz.2019.06.2802
- By:
- Publication type:
- Article
A suitable time point for quantifying the radiochemical purity of <sup>225</sup>Ac-labeled radiopharmaceuticals.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00151-y
- By:
- Publication type:
- Article
Decreased CSF clearance and increased brain amyloid in Alzheimer's disease.
- Published in:
- Fluids & Barriers of the CNS, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12987-022-00318-y
- By:
- Publication type:
- Article
Impact of elution impurities on DOTA and NOTA labeling with two commercial <sup>68</sup>Ge/<sup>68</sup>Ga generators.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2018, v. 317, n. 3, p. 1485, doi. 10.1007/s10967-018-6011-1
- By:
- Publication type:
- Article
Differential in radiosensitizing potency of enantiomers of the fatty acid synthase inhibitor C75.
- Published in:
- Chirality, 2017, v. 29, n. 1, p. 10, doi. 10.1002/chir.22668
- By:
- Publication type:
- Article
A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα).
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 5, p. 686, doi. 10.1007/s11307-021-01593-1
- By:
- Publication type:
- Article
Population-based input function for TSPO quantification and kinetic modeling with [11C]-DPA-713.
- Published in:
- EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00381-8
- By:
- Publication type:
- Article
Reasons for Discordance between 68 Ga-PSMA-PET and Magnetic Resonance Imaging in Men with Metastatic Prostate Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2056, doi. 10.3390/cancers16112056
- By:
- Publication type:
- Article
A convenient solid-phase synthesis methodology for preparing peptide-derived molecular imaging agents — Synthesis, characterization, and in vitro screening of Tc(I) – chemotactic peptide conjugates.
- Published in:
- Canadian Journal of Chemistry, 2005, v. 83, n. 12, p. 2060, doi. 10.1139/V05-224
- By:
- Publication type:
- Article
[<sup>11</sup>C,<sup>127</sup>I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites.
- Published in:
- Synapse, 2001, v. 39, n. 4, p. 332, doi. 10.1002/1098-2396(20010315)39:4<332::AID-SYN1017>3.0.CO;2-X
- By:
- Publication type:
- Article
Altropane, a SPECT or PET imaging probe for dopamine neurons: I. dopamine transporter binding in primate brain.
- Published in:
- Synapse, 1998, v. 29, n. 2, p. 93, doi. 10.1002/(SICI)1098-2396(199806)29:2<93::AID-SYN1>3.0.CO;2-5
- By:
- Publication type:
- Article
Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters.
- Published in:
- Synapse, 1998, v. 29, n. 2, p. 128, doi. 10.1002/(SICI)1098-2396(199806)29:2<128::AID-SYN4>3.0.CO;2-9
- By:
- Publication type:
- Article
Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
- Published in:
- Synapse, 1998, v. 29, n. 2, p. 116, doi. 10.1002/(SICI)1098-2396(199806)29:2<116::AID-SYN3>3.0.CO;2-A
- By:
- Publication type:
- Article
Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.
- Published in:
- Synapse, 1996, v. 24, n. 3, p. 262, doi. 10.1002/(SICI)1098-2396(199611)24:3<262::AID-SYN9>3.0.CO;2-C
- By:
- Publication type:
- Article
Preoperative imaging of colorectal cancers. Targeting the epithelial membrane antigen with a radiation-labeled monoclonal antibody.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Synthesis and Evaluation of 11 C-Labeled Triazolones as Probes for Imaging Fatty Acid Synthase Expression by Positron Emission Tomography.
- Published in:
- Molecules, 2022, v. 27, n. 5, p. 1552, doi. 10.3390/molecules27051552
- By:
- Publication type:
- Article
Poster 203: Mechanical Loading Effects on OA Progression Following ACL Injury and Reconstruction in a Murine Model: Radiographic Assessment of Synovial Fibroblast Activity.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
PET Tracers for Imaging Cardiac Function in Cardio-oncology.
- Published in:
- Current Cardiology Reports, 2022, v. 24, n. 3, p. 247, doi. 10.1007/s11886-022-01641-4
- By:
- Publication type:
- Article
Targeting prostate cancer: Prostate‐specific membrane antigen based diagnosis and therapy.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 1, p. 40, doi. 10.1002/med.21508
- By:
- Publication type:
- Article
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with I-MIP-1095.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 6, p. 950, doi. 10.1007/s00259-017-3665-9
- By:
- Publication type:
- Article
Synthesis and pre-clinical evaluation of a new class of high-affinity F-labeled PSMA ligands for detection of prostate cancer by PET imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 4, p. 647, doi. 10.1007/s00259-016-3556-5
- By:
- Publication type:
- Article
Radiation dosimetry and first therapy results with a I/I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 7, p. 1280, doi. 10.1007/s00259-014-2713-y
- By:
- Publication type:
- Article
Is nano too big?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
PSMA as a target for radiolabelled small molecules.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species.
- Published in:
- EJNMMI Research, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2191-219X-3-73
- By:
- Publication type:
- Article
Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 656, doi. 10.2967/jnumed.118.221150
- By:
- Publication type:
- Article
A Single Dose of <sup>225</sup>Ac-RPS-074 Induces a Complete Tumor Response in an LNCaP Xenograft Model.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 649, doi. 10.2967/jnumed.118.219592
- By:
- Publication type:
- Article
Intraindividual Comparison of <sup>99m</sup>Tc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand <sup>99m</sup>Tc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 9, p. 1373, doi. 10.2967/jnumed.117.200220
- By:
- Publication type:
- Article
Identification of Ligands and Translation to Clinical Applications.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 27S, doi. 10.2967/jnumed.116.186791
- By:
- Publication type:
- Article
Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 17S, doi. 10.2967/jnumed.116.186775
- By:
- Publication type:
- Article
Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 9, p. 1442, doi. 10.2967/jnumed.116.188722
- By:
- Publication type:
- Article
Phase 2 Study of <sup>99</sup>mTc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 9, p. 1408, doi. 10.2967/jnumed.116.187807
- By:
- Publication type:
- Article
The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, p. 79S, doi. 10.2967/jnumed.115.170720
- By:
- Publication type:
- Article
Comprehensive Quality Control of the ITG <sup>68</sup>Ge/<sup>68</sup>Ga Generator and Synthesis of <sup>68</sup>Ga-DOTATOC and <sup>68</sup>Ga-PSMA-HBED-CC for Clinical Imaging.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 9, p. 1402, doi. 10.2967/jnumed.115.171249
- By:
- Publication type:
- Article
PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 293, doi. 10.2967/jnumed.114.147181
- By:
- Publication type:
- Article
<sup>99m</sup>Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 11, p. 1791, doi. 10.2967/jnumed.114.140426
- By:
- Publication type:
- Article
Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free <sup>123</sup>I-Iobenguane.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 5, p. 765, doi. 10.2967/jnumed.113.124057
- By:
- Publication type:
- Article
Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide <sup>131</sup>I-BA52.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 1, p. 9, doi. 10.2967/jnumed.112.112789
- By:
- Publication type:
- Article
<sup>99m</sup>Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 8, p. 1369, doi. 10.2967/jnumed.112.116624
- By:
- Publication type:
- Article
The Role of Copper in Disulfiram-Induced Toxicity and Radiosensitization of Cancer Cells.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 6, p. 953, doi. 10.2967/jnumed.112.113324
- By:
- Publication type:
- Article
First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 3, p. 380, doi. 10.2967/jnumed.112.111203
- By:
- Publication type:
- Article
Dose Escalation Study of No-Carrier-Added <sup>131</sup>I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 7, p. 1155, doi. 10.2967/jnumed.111.098624
- By:
- Publication type:
- Article
Inhibition of Poly(ADP-Ribose) Polymerase Enhances the Toxicity of <sup>131</sup>I-Metaiodobenzylguanidine/Topotecan Combination Therapy to Cells and Xenografts That Express the Noradrenaline Transporter.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 7, p. 1146, doi. 10.2967/jnumed.111.095943
- By:
- Publication type:
- Article
<sup>123</sup>I-MIP-1072, a Small-Molicule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at monitoring Tumor Response to Taxane Therapy.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 7, p. 1087, doi. 10.2967/jnumed.110.086751
- By:
- Publication type:
- Article
Phase I Trial of <sup>90</sup>Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 10, p. 1524, doi. 10.2967/jnumed.110.075226
- By:
- Publication type:
- Article